AURANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Aura Biosciences, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$6.29+0.19 (+3.11%)
Close on Oct 19, 2026
- Market cap
- $596.69M
- P/E (TTM)
- –
- Dividend yield
- –
Community
Notes and questions about Aura Biosciences from other investors
No posts about AURA yet
Discussion opens with sign-in. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.